Canaccord Genuity Starts Cerulean Pharma (CERU) at Buy
Tweet
Share
E-mailGet Alerts CERU Hot Sheet
Price: $0.66 --0%
Rating Summary:
3 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Rating Summary:
3 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Join SI Premium – FREE
Canaccord Genuity initiates coverage on Cerulean Pharma (NASDAQ: CERU) with a Buy rating and a price target of $11.00.
For an analyst ratings summary and ratings history on Cerulean Pharma click here. For more ratings news on Cerulean Pharma click here.
Shares of Cerulean Pharma closed at $6.75 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Syntholene Energy closes $2.3M non-brokered private placement
- Erste Group Starts Union Pacific (UNP) at Buy
- Deutsche Bank Starts Rhythm Pharmaceuticals (RYTM) at Hold
Create E-mail Alert Related Categories
New CoverageRelated Entities
Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
